If you're researching light therapy for vitamin D, the answer is specific: narrowband UVB. Not red light. Not full-spectrum bright light. Narrowband UVB — a specific band within the ultraviolet spectrum — is the only light therapy modality with documented activity in the vitamin D synthesis pathway.
A brief history of narrowband UVB
Narrowband UVB phototherapy was developed in the 1980s by dermatologists looking for a more targeted alternative to broadband UVB treatment. The 311–313 nm band was identified as the most therapeutically active portion of the UVB spectrum while producing less of the erythema (sunburn response) associated with broader UV exposure.
By the 1990s, narrowband UVB had become the standard of care in phototherapy clinics for several skin conditions. Its safety profile over long-term use has been evaluated in multiple large studies.
The photochemical mechanism
When narrowband UVB photons contact the epidermis, they trigger the isomerization of 7-dehydrocholesterol (7-DHC) — a naturally occurring molecule in the skin — into pre-vitamin D3. This molecule spontaneously converts to vitamin D3, which then enters circulation for processing in the liver (conversion to 25-hydroxyvitamin D) and kidneys (conversion to the active form, 1,25-dihydroxyvitamin D3).
This pathway is identical whether the UVB source is sunlight or a narrowband lamp. The skin does not distinguish between the two — only the wavelength and dose matter. (Wacker M, Holick MF. Dermatoendocrinol. 2013.)
Why other light therapies don't address vitamin D
Red light (630–700 nm) and near-infrared (700–1100 nm) are entirely in the visible and infrared range. They have no UV component and cannot trigger the 7-DHC conversion. SAD lamps emit visible white light designed to enter through the eyes and support circadian rhythm — also no UV, also no vitamin D.
This distinction is not a marketing point. It's basic photochemistry.
Narrowband UVB in consumer devices
The availability of narrowband UVB in consumer devices is relatively recent. Historically, UVB treatment required a clinical setting. Consumer devices now bring the same spectrum to home use — with the same fundamental requirement: appropriate session duration, correct distance, and eye protection.
Mitolux BTS2 uses narrowband UVB (295–315 nm) as one of its three light spectrums, paired with red light and NIR for a multi-spectrum session.
Disclaimer: Mitolux is intended for general wellness and self-care use. Individual experiences vary. This content is for informational purposes only and does not constitute medical advice. Mitolux is not intended to diagnose, treat, cure, or prevent any disease. Use only as directed. Consult a qualified healthcare professional before use if you have a medical condition, are pregnant, or take medications that increase light sensitivity.